Acumen can refer to different entities, but neither the global non-profit impact fund nor the clinical-stage biotech firm represents a massive multinational conglomerate. Acumen (the non-profit impact investor) operates globally with regional offices across multiple continents, managing moderate asset pools and a specialized workforce. Similarly, Acumen Pharmaceuticals is a small-cap, specialized biotechnology firm with a lean team of clinical scientists and researchers.